Science & Co review

Science & Co advertises $79 a month for semaglutide and $125 for tirzepatide, and both are twelve-month plan rates. It deserves credit for how it handles that: the month-to-month prices, $149 and $199, are printed right beside them. The promise around them is genuinely strong — one price at every dose, no membership fee, no cancellation fee, free shipping, all fifty states and DC. What's missing is everyone behind it. No pharmacy is named, no medical group is named, and the footer confirms the company isn't a compounding facility without saying who is. Its social proof is weaker still: the same customer quote appears three times in a row.

Science and Co, Inc., a cash-pay telehealth service spanning three lines — weight loss (compounded semaglutide, compounded tirzepatide, a GLP-1/GIP microdose), longevity (sermorelin, glutathione) and hormone replacement (testosterone injection, testosterone cream, enclomiphene) — plus a lab panel offering. It states it is not a 503A or 503B compounding facility and that medications come from state-licensed US compounding pharmacies with batch-level third-party testing for purity and potency.

Asynchronous, through a roughly five-minute health questionnaire reviewed by a provider licensed in your state, with the same provider stated to stay with you month to month. The hormone path is properly gated: testosterone and enclomiphene are prescribed only after bloodwork confirms low levels, the service states which labs are needed, and it states that nothing is prescribed before results are in. It is also unusually direct that enclomiphene is not FDA-approved for raising testosterone and needs the same monitoring as any hormone therapy. Neither the pharmacy nor the medical group is ever named — "a state licensed US compounding pharmacy" and "a provider licensed in your state" are as specific as the site gets.

Low, and tied to a long commitment that the site does disclose. Compounded semaglutide is $79/month on the twelve-month plan against a $149 month-to-month price shown struck through beside it; tirzepatide is $125 against $199. Sermorelin and glutathione are each $69/month on the twelve-month plan. The FAQ states the basis directly: "Plans start at $79 a month on the 12 month plan." Around that, the terms are good — the same price at every dose, no hidden fees, no monthly membership, free shipping on every order, no lock-in, no cancellation fee, and cancellation allowed up to 72 hours before the next processing date. The hormone pages publish no price at all, so TRT cannot be compared against anything without starting an intake.

Compounded semaglutide and tirzepatide, a GLP-1/GIP microdose, sermorelin, glutathione, testosterone by injection and cream, and enclomiphene. The compounded disclosure is correct and repeated: not approved or evaluated by the FDA for safety, effectiveness or quality, prescription required. On the evidence: the GLP-1 outcome data belongs to the branded products; sermorelin has a real growth-hormone-axis mechanism with thin long-term outcome data; injectable glutathione has essentially no controlled human outcome evidence; testosterone replacement has real randomized data in symptomatic hypogonadism; enclomiphene is not FDA-approved for this use, which the site itself says.